Minerva Neurosciences (NERV) Misses Q4 EPS by 2540c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($25.51), $25.40 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• MAIA Biotechnology (MAIA) files $150M mixed shelf
• Two Harbors receives final approval for CrossCountry Mortgage merger